AlenCiken 의 NASDAQ:OPGN 용 $OPGN catalyst: FDA decision Acuitas AMR Gene Panel

trendanalysis chartpattern fundamental biotech biotechnology biotechstocks biotechs biotechstock biotehnology

Hyping on twitter: Added New position $OPGN primarily for the top catalyst FDA decision Acuitas AMR Gene Panel. In addition, pipeline includes Broad pathogen and Antimicrobial Resistance Marker coverage. 53 M market cap. Eyeing $3.3 breakout target towards $4 plus. Should spike on FDA decision.